BRCA2 and ovarian carcinoma: To date, no studies have applied a wholly unbiased WES-based approach to ovarian carcinoma predisposition gene discovery in a case cohort selected for HGSOC and enriched for hereditary cases where BRCA1 and BRCA2 involvement have been excluded.